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Genetic epidemiology continues to rely heavily on association studies to identify genetic factors that enhance risk or provide protection against susceptibility to complex diseases. Research tools for testing for associations between genetic factors and disease status include the traditional case-control study design, approaches using family trios specifically developed for genetic studies, and hybrid methods that integrate case-control and family trio designs to enhance statistical power. A potential concern when comparing unrelated casecontrol individuals is population stratification bias (PSB), which is a form of confounding due to differences in genetic ancestry between cases and controls. PSB can produce spurious results in the absence of association, and may mask or even reverse the effect of a true association (1, 2) . In the presence of PSB, estimates from case-control analyses are unreliable, and therefore combining individual-level casecontrol and family trio designs is inappropriate.
To guard against PSB, case-control study designs can restrict participation to persons belonging to a common racial/ ethnic group in the hope of sampling a genetically homogenous population. However, sufficient variation in genetic ancestry can persist to generate substantial risk of false-positive findings, even in well-designed studies, such as those restricted to Americans of European descent (3) or Icelandic population samples (4) . PSB can also be corrected by adjusting analytical results using data on race/ethnicity; however, good-quality information on race/ethnicity is hard to collect, and broad classifications may not be sensitive to possible underlying population admixture, resulting in residual confounding. Furthermore, self-reported race/ethnicity can be based on cultural identity, language spoken, or country of origin, and these factors may not accurately reflect underlying genetic structure. Alternatively, information regarding genetic ancestry can be derived from genotype data, but such approaches (5-8) require genotyping a large number of markers across the genome, and therefore cannot be readily applied in practice to candidate gene or confirmation studies limited to few loci.
Concerns about PSB have driven the development of robust family-based analyses, which are considered the gold standard of genetic association analyses. Originally, family trios including a case child and his/her parents (case trios) were used to test for preferential allele transmissions from parents to the affected offspring. In comparison with case-control analyses, case-trio methods are more (less) powerful for rare (common) diseases (9, 10) . For common diseases, the power of case-trio analyses can be improved by including unaffected siblings and/or control trios (11, 12) , for which data may be readily available or collected for assessment of distortion of allele transmission that is independent of disease (13) .
Statistical power to detect a genetic association can also be improved by combining case-control and family trios when data on both are available within the same study. A number of hybrid methods have been proposed for integrating data types or combining case-control and case-trio estimates (14, 15) . In their review, Infante-Rivard et al. (14) applied selected hybrid methods to a candidate gene study of acute lymphoblastic leukemia (ALL) including a rich collection of case-control subjects with and without parental data (the Quebec Childhood Leukemia Study, 1980 Study, -2000 . Each hybrid method employed various components of the available individual and family data, but none utilized all of the data including control trios. One of our aims in this article is to present information on how and when control trios may be used in genetic association analyses.
A key component of all existing hybrid methods is an initial PSB test assessing equality between case-control and family-trio estimates using a predetermined significance level, typically a PSB ¼ 5%. Combined analyses are performed only if the PSB test result is nonsignificant. If significant evidence for PSB is detected, then robust family-trio analyses are selected. A similar selection strategy has been proposed for quantitative trait analysis using unrelated individuals and family data (16); however, simulations showed that in the presence of PSB, the type I error of this strategy (at a nominal 5% level with a PSB ¼ 5%) was unacceptably high (17) . An alternative weighted approach was proposed that in the presence of PSB had type I error closer to the nominal level, as well as improved accuracy and positive predictive value (17) .
In this report, we consider analyses of case-control individuals with or without parents, in a setting similar to that of the ALL study (14) . We demonstrate how both case and control trios can be used in genetic association tests, and then compare these with case-control and case-trio analyses. In addition, we describe and compare the performance of 4 tests for detection of PSB, extend the weighted approach (17) to analyses of binary disease status, and compare it with the hybrid method of Chen and Lin (18) . Practical application of the methods is illustrated using data from the ALL candidate gene study (14) .
MATERIALS AND METHODS
Consider a case-control design with a total of N Cas case subjects and N Con control subjects including (N S ¼ N S,Cas þ N S,Con ) ''singletons'' without parents and (N T ¼ N T,Cas þ N T,Con ) trios (both parents available). Let the disease status of each trio offspring and singleton
Here, we assume that complete genotype data are available for all trio members and singletons at a single nucleotide polymorphism with 2 possible alleles. Each individual inherits 1 allele from each parent, resulting in one of 3 possible allele combinations, which for analyses can be quantified as a 1-component genotype score G. We assume a ''gene dose'' or ''additive'' model with G equal to 0, 1, or 2 copies of the minor frequency allele in specifying the methods and in subsequent evaluations by simulation. An alternative dominant inheritance model is also applied to the ALL data. Statistical methods for assessing genetic association using different data components or combinations are summarized in Table 1 and described below.
Association analyses using unrelated case-control individuals
Individual-level analyses comparing genotype frequencies between unrelated case and control individuals are typically performed using logistic regression models that condition only on the genotype score G i of each trio offspring and singleton i, i ¼ 1, . . ., N.
Following Abecasis et al. (16) , we refer to the above as ''total-association'' case-control analyses because the greatest efficiency is achieved when all independent case-control individuals are included, irrespective of parental genotype availability. The maximum likelihood estimate b b tot (equation 1) corresponds to the natural logarithm of the genotype odds ratio (log OR) and may be subject to PSB. Under the gene-dose model, expð b b tot Þ represents the ratio of disease odds for carriers of 1 (2) minor allele as compared with carriers of 0 (1) minor alleles. Similarly, expð2 b b tot Þ estimates the odds ratio comparing rare and common homozygous individuals.
Family-based analyses using case trios
The conditional on parental genotypes (CPG) likelihood (19, 20) is often applied to case trios to test for over-/undertransmission of alleles from parents to case offspring. In contrast to ''total-association'' analyses, the CPG likelihood conditions on the offspring G i and parental genotypes G m,i (mother) and
Derivation of the CPG likelihood is provided in the Web Appendix, which is posted on the Journal's website (http:// aje.oxfordjournals.org/). The CPG parameter estimate b b cas cpg is robust to PSB and corresponds to the natural logarithm of the genotype relative risk (log RR). Under a gene-dose model, expð b b cas cpg Þ estimates the disease risk ratio for case offspring that inherit 1 (2) minor allele from heterozygous parents (homozygous parents are uninformative and are not used in the CPG likelihood) compared with case offspring inheriting 0 (1) minor alleles.
It is possible to perform CPG analyses using only control trios (parents with unaffected offspring); however, such analyses are typically not performed because of low power to detect undertransmission of risk alleles to unaffected offspring, especially for rare diseases. Often, the aim of collecting data on control trios is to test for transmission ratio distortion, which is a biologic phenomenon that can lead to false-positive results in CPG analyses using only case trios. However, when data on both case and control trios are available, family-based tests can be derived that compare allele transmissions to case offspring with those to control offspring.
Family-based analyses using both case and control trios
In analogy with the linear model described by Abecasis et al. (16), we propose the following logistic regression model with family genotype information from both case and control trios N T ¼ (N T,Cas þ N T,Con ) decomposed into betweenfamily (b b ) and within-family (b w ) components. a positive (negative) difference of ðG i À G M i Þ ¼ 61 implies that the offspring has inherited an additional copy of the minor (major) allele compared with the expected number. In our simulation study below, we demonstrate that b b b comparing expected offspring genotypes between families is subject to PSB, whereas b b w comparing within-family differences between observed and expected offspring genotypes is robust.
Note that within-family allele transmissions are used to calculate both family-based estimates b b 
using weights, w tot and w cpg , based on the corresponding variance and covariance estimates (details provided in the Web Appendix). This method assumes that b b tot (representing log OR and subject to PSB) is comparable to b b cas cpg (representing log RR and robust to PSB), which is true when both PSB and association are absent ðb tot ¼ b cas cpg ¼ 0Þ. Under the association alternative, although the inequality j b tot j>j b cas cpg j is strictly true, the difference between b b tot and b b cas cpg will be small, and estimates may be combined if PSB is absent and disease prevalence is low. However, as the disease prevalence increases, the log OR parameter b tot will be systematically and increasingly larger in magnitude than the log RR parameter b 
Tests for PSB
Among hybrid methods, some form of PSB assessment is recommended to determine whether combining individual-level and family-based analyses is appropriate. For example, Chen and Lin (18) 
Association estimates in hybrid analyses
Chen and Lin (18) proposed selection of a final estimate b b sel , determined as b b cmb (most efficient but subject to PSB) or b b cas cpg (robust to PSB) depending on whether the P value (p eq ) from the PSB test Zðb tot À b cas cpg Þ exceeds a prespecified testing level (a PSB ).
The indicator function I(p eq a PSB ) takes the value 1 or 0 when the condition (p eq a PSB ) is true or false. Essentially 
When PSB is present, the weighted estimate b b wgt computed in practice using finite samples will have some bias. However, as sample sizes increase toward infinity, the power to detect PSB approaches 1, the PSB test P value approaches 0, and b b wgt approaches the unbiased CPG estimate b b cas cpg . Therefore, the weighted estimate b b wgt is asymptotically valid. To test the null hypothesis of no genetic association, H 0 : ðb wgt ¼ 0Þ, we derive the test statistic
using a bootstrap variance estimate, which in practice we evaluate using 200 bootstrap samples. Details regarding the derivation and computation of Z(b wgt ) are provided in the Web Appendix.
estimates across a range of disease prevalence, degree of association, and PSB levels. The type I error (absence of PSB) and power to detect PSB of the 4 Z eq tests were computed at the nominal testing level a PSB ¼ 5%. The type I error of genetic association tests, Z(b tot ), Zðb cas cpg Þ, Z(b b ), Z(b w ), Z(b cmb ), Z(b sel ) (computed at PSB testing levels a PSB ¼ 0.1%, 1%, 5%, 10%, 20%, and 50%) and Z(b wgt ), was computed at the nominal level a assoc ¼ 5%. Because type I error may not be nominal when PSB is present, power estimates which assume nominal type I error are not valid, and therefore association tests were compared with respect to accuracy (proportion of results that are true-positive or true-negative) and positive predictive value (proportion of true-positive results among true-positive and false-positive results) as formally defined in the Web Appendix. In addition, the ''flip-flop'' rate was computed to assess significant findings with the direction of the true association signal reversed by PSB, a phenomenon that can lead to an inaccurate association estimate.
Complete details regarding the design and implementation of simulations are provided in the Web Appendix. Briefly, simulated data sets included genotypes at a single nucleotide polymorphism for N T,Cas ¼ N T,Con ¼ 100 and N S,Cas ¼ N S,Con ¼ 100 trios and singletons drawn respectively from a mixture of 2 populations with disease prevalence k 1 and k 2 , and minor allele frequencies q 1 and q 2 . Genotype scores (18) method. Positive PSB levels were determined by specifying different population disease prevalences k 1 /k 2 ¼ (0.01/0.05) and minor allele frequencies q 1 ¼ 0.1, q 2 ¼ (0.2, 0.3, . . . , 0.6). Negative PSB of the same magnitude was generated by exchanging the minor allele frequencies between populations, (q 2 À q 1 ) ¼ À(0.1, 0.2, . . ., 0.5). For each simulation scenario, 1,000 replicate data sets were generated and analyzed using the software package R (21).
RESULTS

Comparisons of genetic association estimates and tests
In all scenarios with no association and no PSB, the mean of each b b tot , b b estimates showed increasing departures with increasing disease prevalence (Figure 1, part B) . These results illustrate divergence between log OR and log RR estimates with increasing disease prevalence and confirm that even without PSB, combining b b tot and b b cas cpg estimates is appropriate only for a rare disease.
As expected, when disease prevalence was less than or equal to 10% and a combined analysis was appropriate, the combined test Z(b cmb ) had the highest power to detect an association (Figure 2, part B) . However, for disease prevalence greater than 20%, the ''total-association'' test Z(b tot ) had the greatest power. The power of the case-control trio test Z(b w ) was constant across different disease prevalence levels ( Figure 2, part B) . In contrast, the power of the casetrio test Zðb 
Tests for PSB
The type I error of all PSB tests was close to the nominal testing level a PSB ¼ 5% under scenarios corresponding to the association null (b ¼ 0) and alternative (b ¼ 0.44) hypotheses with disease prevalence less than or equal to 10% (for more details, see the Web Appendix, including Web Figure 1 ). However, in the presence of association, as the disease prevalence increased and the log OR and log RR estimates became more divergent, the type I error of (17) . Z(b wgt ) had type I error closer to the nominal level a assoc ¼ 5% (Figure 3, part A) , a lower ''flip-flop'' rate ( Figure 3, part B) , and consistently greater positive predictive value (Figure 3 , part D) than did Z(b sel ) (a PSB ¼ 5%). Accuracy was slightly larger for Z(b sel ) (a PSB ¼ 5%) when PSB was absent or very low; however, for all other PSB levels, accuracy was slightly greater for Z(b wgt ) (Figure 3, part C) . Z(b sel ) computed using the more stringent (liberal) PSB significance levels a PSB ¼ 0.1% and a PSB ¼ 1% (10%, 20%, and 50%) showed an increased (decreased) type I error and flip-flop , computed at various population stratification bias (PSB) testing levels (a PSB ¼ 0.1%, 1%, 5%, 10%, 20%, 40%, and 50%). Data were generated from 2 populations with disease prevalence k 1 /k 2 ¼ 0.01/0.05 and minor allele frequency (MAF) differences (q 2 À q 1 ) ¼ 0, <0, and >0, corresponding to the absence of PSB, negative PSB, and positive PSB, respectively.
Am J Epidemiol. 2012;176(1):70-79 rate (Figure 3, parts A and B) . Both accuracy and the positive predictive value of Z(b sel ) increased with increasing PSB testing level a PSB (Figure 3, parts B and C) . At the testing level a assoc ¼ 5%, the performance of Z(b wgt ) was most similar to that of Z(b sel ) using the PSB significance level of a PSB ¼ 50% (Figure 3 ).
Analyses of childhood leukemia and NQO1 C609T genotype
As an illustration, we examined the association between childhood ALL and the C609T polymorphism on the candidate gene NAD(P)H: quinone oxidoreductase 1 (NQO1), as described by Infante-Rivard et al. (22) . These ALL data included 451 case trios, 411 control trios, and additionally 99 cases and 91 control subjects with complete genotype data at the NQO1 C609T locus. Analyses were performed using both gene-dose and dominant inheritance models for the minor frequency T allele. The significance of all tests was assessed at the 5% level. Analyses were performed using the software program R (21), which is freely available; sample code for the ALL data analyses is available at http://research. lunenfeld.ca/Mprime/DEFAULT.ASP?page¼Software.
Strong evidence for association was detected by means of ''total-association'' analyses using all cases (n ¼ 550) and controls (n ¼ 502) (with parental genotypes ignored) for both gene-dose and dominant models ( Table 2) . Although the b b cas cpg estimate based on 451 case trios suggested increased transmission of the T allele, significant association was detected only for the dominant model. These results underscore the importance of assuming an appropriate genetic inheritance model. For both models, stronger evidence for association was detected by analyses using case-control trios as compared with case-trio analyses. Although ALL is a very rare disease with an estimated annual incidence of 4 cases per 100,000 children (23) , between-family analyses provide stronger evidence for association than CPG analyses using only case trios, suggesting that the 411 control trios contribute information regarding undertransmission of the T allele ( Table 2) are almost equal, and corresponding tests detected significant association between ALL and the T allele. However, for the gene-dose model with p eq ¼ 0.61, the selection test Z(b sel ) is significant, whereas the weighted test Z(b wgt ) is nonsignificant because more weight is given to the case-trio analyses in which there is weak evidence for association.
DISCUSSION
In this report, we have developed, evaluated, and illustrated the application of hybrid statistical approaches for (24) . Although our development and assessment of the ''between-within'' model is for retrospective studies, this model can be applied similarly to prospective cohort or cross-sectional study designs. For family-based analyses, we derived the theoretical relation between estimates computed using only case trios b b Here, we have also presented a weighted approach for analyses of case-control individuals and case trios, specifically providing an alternative to the selection strategy (18) . Our simulation study was purposefully designed to assess the performance of PSB tests and to compare the weighted and selection methods under the assumption of a rare disease, when log OR and log RR parameters may be combined. For the scenarios considered, Zðb b À b cas cpg Þ was the most powerful PSB test, and its P value provided the basis for both weighted and selection analyses. Results of weighted and selection analyses of case-control data were very similar to results obtained for quantitative trait analyses (17) . Over a broad range of simulated PSB levels, the weighted test Zðb wgt Þ adapted to the PSB evidence, whereas Z(b sel ) with a PSB < 50% selected the biased estimate more frequently, producing increased type I error. The weighted test had lower type I error than the selection test over a broad range of PSB levels. The weighted test also outperformed the selection approach in terms of accuracy and positive predictive value, except when PSB was absent or very low. The performance of the weighted test was most similar to selection using a PSB ¼ 50%, which represents the practical choice with no prior knowledge about PSB. Therefore, we recommend the weighted test Z(b wgt ), which does not require specification of a PSB testing level, for analyses of case-control individuals and trios in candidate gene or confirmation studies of rare disease.
When the rare disease assumption is violated and log OR and log RR cannot be combined (disease prevalence >10% based on simulations), the case-control trio estimate ð b b w Þ can be used in place of b b cas cpg Þ using case trios only for both weighted and selection analyses. In our simulation study, the within-family test Z(b w ) had greater power to detect an association than Zðb cas cpg Þ when disease prevalence was greater than 35%. However, as seen in the ALL example, even for a rare disease, case-control trio analyses can provide stronger evidence for association than analyses restricted to case trios. Therefore, additional study is needed to assess the choice of association estimates for weighted and selection analyses and to provide recommendations for optimal analyses when the assumption of a rare disease is violated (disease prevalence >10%). Further study is also warranted to compare the weighted approach with other existing methods (25, 26) combining individual and family data, including approaches specific to genome-wide association analyses (27, 28) .
